Literature DB >> 21332968

Analytical goals for HbA1c: are HbA1c results good enough for optimal use?

Randie R Little1, Curt L Rohlfing.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21332968     DOI： 10.1111/j.1753-0407.2010.00109.x

Source DB:  PubMed          Journal:  J Diabetes        ISSN： 1753-0407            Impact factor:   4.006


× No keyword cloud information.
  3 in total

1.  Effectiveness of groups for adolescents with type 1 diabetes mellitus and their parents.

Authors:  Jessica C Kichler; Astrida S Kaugars; Patricia Marik; Laura Nabors; Ramin Alemzadeh
Journal:  Fam Syst Health       Date:  2013-08-19       Impact factor: 1.950

2.  The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.

Authors:  S L Stocker; K M Morrissey; S W Yee; R A Castro; L Xu; A Dahlin; A H Ramirez; D M Roden; R A Wilke; C A McCarty; R L Davis; C M Brett; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2012-10-17       Impact factor: 6.875

3.  Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin.

Authors:  S Goswami; S W Yee; S Stocker; J D Mosley; M Kubo; R Castro; J A Mefford; C Wen; X Liang; J Witte; C Brett; S Maeda; M D Simpson; M M Hedderson; R L Davis; D M Roden; K M Giacomini; R M Savic
Journal:  Clin Pharmacol Ther       Date:  2014-05-22       Impact factor: 6.875
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.